4.7 Article

Methylglyoxal Impairs Sister Chromatid Separation in Lymphocytes

Journal

Publisher

MDPI
DOI: 10.3390/ijms23084139

Keywords

methylglyoxal; chromosomal instability; sister chromatid separation; proteomics

Funding

  1. Australian Institute of Health andWelfare, Government Research Training Program Scholarship

Ask authors/readers for more resources

This study reveals that the glycolytic by-product MGO can drive chromosomal instability by preventing sister chromatid separation. It identifies several MGO-modified mitotic proteins, including those involved in the separation and cohesion of sister chromatids.
The accurate segregation of sister chromatids is complex, and errors that arise throughout this process can drive chromosomal instability and tumorigenesis. We recently showed that methylglyoxal (MGO), a glycolytic by-product, can cause chromosome missegregation events in lymphocytes. However, the underlying mechanisms of this were not explored. Therefore, in this study, we utilised shotgun proteomics to identify MGO-modified proteins, and label-free quantitation to measure changes in protein abundance following exposure to MGO. We identified numerous mitotic proteins that were modified by MGO, including those involved in the separation and cohesion of sister chromatids. Furthermore, the protein abundance of Securin, an inhibitor of sister chromatid separation, was increased following treatment with MGO. Cytological examination of chromosome spreads showed MGO prevented sister chromatid separation, which was associated with the formation of complex nuclear anomalies. Therefore, results from this study suggest MGO may drive chromosomal instability by preventing sister chromatid separation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available